The global CAR T-Cell Immunotherapy market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
AbbVie
Celgene
Kite Pharma
Oxford BioMedica
Novartis
Gilead
Pfizer
Cellectis
Bellicum
Mustang Bio
CARsgen Therapeutics
Xyphos
Minerva Biotechnologies
Adaptimmune
Ziopharm Oncology
Aurora Biopharma
Creative Biolabs
By Types:
Monotherapy
Combination Therapy
By Applications:
Hematologic Malignancies
Solid Malignancies
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global CAR T-Cell Immunotherapy Market Size Analysis from 2023 to 2028
1.5.1 Global CAR T-Cell Immunotherapy Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global CAR T-Cell Immunotherapy Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global CAR T-Cell Immunotherapy Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: CAR T-Cell Immunotherapy Industry Impact
Chapter 2 Global CAR T-Cell Immunotherapy Competition by Types, Applications, and Top Regions and Countries
2.1 Global CAR T-Cell Immunotherapy (Volume and Value) by Type
2.1.1 Global CAR T-Cell Immunotherapy Consumption and Market Share by Type (2017-2022)
2.1.2 Global CAR T-Cell Immunotherapy Revenue and Market Share by Type (2017-2022)
2.2 Global CAR T-Cell Immunotherapy (Volume and Value) by Application
2.2.1 Global CAR T-Cell Immunotherapy Consumption and Market Share by Application (2017-2022)
2.2.2 Global CAR T-Cell Immunotherapy Revenue and Market Share by Application (2017-2022)
2.3 Global CAR T-Cell Immunotherapy (Volume and Value) by Regions
2.3.1 Global CAR T-Cell Immunotherapy Consumption and Market Share by Regions (2017-2022)
2.3.2 Global CAR T-Cell Immunotherapy Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global CAR T-Cell Immunotherapy Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global CAR T-Cell Immunotherapy Consumption by Regions (2017-2022)
4.2 North America CAR T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia CAR T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.4 Europe CAR T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia CAR T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia CAR T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East CAR T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.8 Africa CAR T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania CAR T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
4.10 South America CAR T-Cell Immunotherapy Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America CAR T-Cell Immunotherapy Market Analysis
5.1 North America CAR T-Cell Immunotherapy Consumption and Value Analysis
5.1.1 North America CAR T-Cell Immunotherapy Market Under COVID-19
5.2 North America CAR T-Cell Immunotherapy Consumption Volume by Types
5.3 North America CAR T-Cell Immunotherapy Consumption Structure by Application
5.4 North America CAR T-Cell Immunotherapy Consumption by Top Countries
5.4.1 United States CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
5.4.2 Canada CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
5.4.3 Mexico CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 6 East Asia CAR T-Cell Immunotherapy Market Analysis
6.1 East Asia CAR T-Cell Immunotherapy Consumption and Value Analysis
6.1.1 East Asia CAR T-Cell Immunotherapy Market Under COVID-19
6.2 East Asia CAR T-Cell Immunotherapy Consumption Volume by Types
6.3 East Asia CAR T-Cell Immunotherapy Consumption Structure by Application
6.4 East Asia CAR T-Cell Immunotherapy Consumption by Top Countries
6.4.1 China CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
6.4.2 Japan CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
6.4.3 South Korea CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 7 Europe CAR T-Cell Immunotherapy Market Analysis
7.1 Europe CAR T-Cell Immunotherapy Consumption and Value Analysis
7.1.1 Europe CAR T-Cell Immunotherapy Market Under COVID-19
7.2 Europe CAR T-Cell Immunotherapy Consumption Volume by Types
7.3 Europe CAR T-Cell Immunotherapy Consumption Structure by Application
7.4 Europe CAR T-Cell Immunotherapy Consumption by Top Countries
7.4.1 Germany CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
7.4.2 UK CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
7.4.3 France CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
7.4.4 Italy CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
7.4.5 Russia CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
7.4.6 Spain CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
7.4.7 Netherlands CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
7.4.8 Switzerland CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
7.4.9 Poland CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 8 South Asia CAR T-Cell Immunotherapy Market Analysis
8.1 South Asia CAR T-Cell Immunotherapy Consumption and Value Analysis
8.1.1 South Asia CAR T-Cell Immunotherapy Market Under COVID-19
8.2 South Asia CAR T-Cell Immunotherapy Consumption Volume by Types
8.3 South Asia CAR T-Cell Immunotherapy Consumption Structure by Application
8.4 South Asia CAR T-Cell Immunotherapy Consumption by Top Countries
8.4.1 India CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
8.4.2 Pakistan CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
8.4.3 Bangladesh CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia CAR T-Cell Immunotherapy Market Analysis
9.1 Southeast Asia CAR T-Cell Immunotherapy Consumption and Value Analysis
9.1.1 Southeast Asia CAR T-Cell Immunotherapy Market Under COVID-19
9.2 Southeast Asia CAR T-Cell Immunotherapy Consumption Volume by Types
9.3 Southeast Asia CAR T-Cell Immunotherapy Consumption Structure by Application
9.4 Southeast Asia CAR T-Cell Immunotherapy Consumption by Top Countries
9.4.1 Indonesia CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
9.4.2 Thailand CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
9.4.3 Singapore CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
9.4.4 Malaysia CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
9.4.5 Philippines CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
9.4.6 Vietnam CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
9.4.7 Myanmar CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 10 Middle East CAR T-Cell Immunotherapy Market Analysis
10.1 Middle East CAR T-Cell Immunotherapy Consumption and Value Analysis
10.1.1 Middle East CAR T-Cell Immunotherapy Market Under COVID-19
10.2 Middle East CAR T-Cell Immunotherapy Consumption Volume by Types
10.3 Middle East CAR T-Cell Immunotherapy Consumption Structure by Application
10.4 Middle East CAR T-Cell Immunotherapy Consumption by Top Countries
10.4.1 Turkey CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
10.4.3 Iran CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
10.4.5 Israel CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
10.4.6 Iraq CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
10.4.7 Qatar CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
10.4.8 Kuwait CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
10.4.9 Oman CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 11 Africa CAR T-Cell Immunotherapy Market Analysis
11.1 Africa CAR T-Cell Immunotherapy Consumption and Value Analysis
11.1.1 Africa CAR T-Cell Immunotherapy Market Under COVID-19
11.2 Africa CAR T-Cell Immunotherapy Consumption Volume by Types
11.3 Africa CAR T-Cell Immunotherapy Consumption Structure by Application
11.4 Africa CAR T-Cell Immunotherapy Consumption by Top Countries
11.4.1 Nigeria CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
11.4.2 South Africa CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
11.4.3 Egypt CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
11.4.4 Algeria CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
11.4.5 Morocco CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 12 Oceania CAR T-Cell Immunotherapy Market Analysis
12.1 Oceania CAR T-Cell Immunotherapy Consumption and Value Analysis
12.2 Oceania CAR T-Cell Immunotherapy Consumption Volume by Types
12.3 Oceania CAR T-Cell Immunotherapy Consumption Structure by Application
12.4 Oceania CAR T-Cell Immunotherapy Consumption by Top Countries
12.4.1 Australia CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
12.4.2 New Zealand CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 13 South America CAR T-Cell Immunotherapy Market Analysis
13.1 South America CAR T-Cell Immunotherapy Consumption and Value Analysis
13.1.1 South America CAR T-Cell Immunotherapy Market Under COVID-19
13.2 South America CAR T-Cell Immunotherapy Consumption Volume by Types
13.3 South America CAR T-Cell Immunotherapy Consumption Structure by Application
13.4 South America CAR T-Cell Immunotherapy Consumption Volume by Major Countries
13.4.1 Brazil CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
13.4.2 Argentina CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
13.4.3 Columbia CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
13.4.4 Chile CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
13.4.5 Venezuela CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
13.4.6 Peru CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
13.4.8 Ecuador CAR T-Cell Immunotherapy Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in CAR T-Cell Immunotherapy Business
14.1 AbbVie
14.1.1 AbbVie Company Profile
14.1.2 AbbVie CAR T-Cell Immunotherapy Product Specification
14.1.3 AbbVie CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Celgene
14.2.1 Celgene Company Profile
14.2.2 Celgene CAR T-Cell Immunotherapy Product Specification
14.2.3 Celgene CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Kite Pharma
14.3.1 Kite Pharma Company Profile
14.3.2 Kite Pharma CAR T-Cell Immunotherapy Product Specification
14.3.3 Kite Pharma CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Oxford BioMedica
14.4.1 Oxford BioMedica Company Profile
14.4.2 Oxford BioMedica CAR T-Cell Immunotherapy Product Specification
14.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Novartis
14.5.1 Novartis Company Profile
14.5.2 Novartis CAR T-Cell Immunotherapy Product Specification
14.5.3 Novartis CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Gilead
14.6.1 Gilead Company Profile
14.6.2 Gilead CAR T-Cell Immunotherapy Product Specification
14.6.3 Gilead CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Pfizer
14.7.1 Pfizer Company Profile
14.7.2 Pfizer CAR T-Cell Immunotherapy Product Specification
14.7.3 Pfizer CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Cellectis
14.8.1 Cellectis Company Profile
14.8.2 Cellectis CAR T-Cell Immunotherapy Product Specification
14.8.3 Cellectis CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Bellicum
14.9.1 Bellicum Company Profile
14.9.2 Bellicum CAR T-Cell Immunotherapy Product Specification
14.9.3 Bellicum CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Mustang Bio
14.10.1 Mustang Bio Company Profile
14.10.2 Mustang Bio CAR T-Cell Immunotherapy Product Specification
14.10.3 Mustang Bio CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 CARsgen Therapeutics
14.11.1 CARsgen Therapeutics Company Profile
14.11.2 CARsgen Therapeutics CAR T-Cell Immunotherapy Product Specification
14.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 Xyphos
14.12.1 Xyphos Company Profile
14.12.2 Xyphos CAR T-Cell Immunotherapy Product Specification
14.12.3 Xyphos CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 Minerva Biotechnologies
14.13.1 Minerva Biotechnologies Company Profile
14.13.2 Minerva Biotechnologies CAR T-Cell Immunotherapy Product Specification
14.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Adaptimmune
14.14.1 Adaptimmune Company Profile
14.14.2 Adaptimmune CAR T-Cell Immunotherapy Product Specification
14.14.3 Adaptimmune CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Ziopharm Oncology
14.15.1 Ziopharm Oncology Company Profile
14.15.2 Ziopharm Oncology CAR T-Cell Immunotherapy Product Specification
14.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 Aurora Biopharma
14.16.1 Aurora Biopharma Company Profile
14.16.2 Aurora Biopharma CAR T-Cell Immunotherapy Product Specification
14.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 Creative Biolabs
14.17.1 Creative Biolabs Company Profile
14.17.2 Creative Biolabs CAR T-Cell Immunotherapy Product Specification
14.17.3 Creative Biolabs CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global CAR T-Cell Immunotherapy Market Forecast (2023-2028)
15.1 Global CAR T-Cell Immunotherapy Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global CAR T-Cell Immunotherapy Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global CAR T-Cell Immunotherapy Value and Growth Rate Forecast (2023-2028)
15.2 Global CAR T-Cell Immunotherapy Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global CAR T-Cell Immunotherapy Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global CAR T-Cell Immunotherapy Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America CAR T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia CAR T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe CAR T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia CAR T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia CAR T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East CAR T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa CAR T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania CAR T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America CAR T-Cell Immunotherapy Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global CAR T-Cell Immunotherapy Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global CAR T-Cell Immunotherapy Consumption Forecast by Type (2023-2028)
15.3.2 Global CAR T-Cell Immunotherapy Revenue Forecast by Type (2023-2028)
15.3.3 Global CAR T-Cell Immunotherapy Price Forecast by Type (2023-2028)
15.4 Global CAR T-Cell Immunotherapy Consumption Volume Forecast by Application (2023-2028)
15.5 CAR T-Cell Immunotherapy Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 2450 |
Date : Jan 2024 |
| Category : Electronics |
Pages : 274 |
Request Sample 
Request Discount 
Inquire Before Buy
